Adameyko, I
However, the data also shows that once older adults are already engaged with GLP-1 treatment, resistance to tablets drops sharply: 43.19% say pills are more appealing than injections 64.94% of injectable users would consider switching This indicates the primary barrier among older adults may not be the pill format itself, but rather initial adoption of GLP-1 treatment in general
Common side effects of GLP-1 include nausea, diarrhea, vomiting, constipation, stomach pain/discomfort, decreased appetite, and indigestion
Phase 2 trials demonstrated A1C reductions of up to 2.02% in participants with type 2 diabetes, bringing average levels from 8.1% down to 6.08%
Reactive oxygen species and cancer paradox: to promote or to suppress
While your body's natural GLP-1 and pharmaceutical GLP-1 receptor agonists share the same basic mechanism of action, there are important differences in their structure, duration of effect, and clinical applications